DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Terizidone

Terizidone

  • Efficacy and Safety of World Health Organization Group 5 Drugs for Multidrug-Resistant Tuberculosis Treatment

    Efficacy and Safety of World Health Organization Group 5 Drugs for Multidrug-Resistant Tuberculosis Treatment

  • Clofazimine As a Treatment for Multidrug-Resistant Tuberculosis: a Review

    Clofazimine As a Treatment for Multidrug-Resistant Tuberculosis: a Review

  • Analysis of Mutations Leading to Para-Aminosalicylic Acid Resistance in Mycobacterium Tuberculosis

    Analysis of Mutations Leading to Para-Aminosalicylic Acid Resistance in Mycobacterium Tuberculosis

  • Terizidone.Pdf

    Terizidone.Pdf

  • SDC 1. Supplementary Notes to Methods Settings Groote Schuur

    SDC 1. Supplementary Notes to Methods Settings Groote Schuur

  • Treatment of Drug-Resistant Tuberculosis an Official ATS/CDC/ERS/IDSA Clinical Practice Guideline Payam Nahid, Sundari R

    Treatment of Drug-Resistant Tuberculosis an Official ATS/CDC/ERS/IDSA Clinical Practice Guideline Payam Nahid, Sundari R

  • Of TB Drug Development: What's on the Horizon (For Patients with Or Without

    Of TB Drug Development: What's on the Horizon (For Patients with Or Without

  • MDR-TB): Evidence and Perspectives

    MDR-TB): Evidence and Perspectives

  • BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available

    BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available

  • Effect of Tablet Crushing on Drug Exposure in the Treatment of Multidrug-Resistant Tuberculosis

    Effect of Tablet Crushing on Drug Exposure in the Treatment of Multidrug-Resistant Tuberculosis

  • Clinical Implications of the Global Multidrug-Resistant Tuberculosis Epidemic

    Clinical Implications of the Global Multidrug-Resistant Tuberculosis Epidemic

  • Alphabetical Listing of ATC Drugs & Codes

    Alphabetical Listing of ATC Drugs & Codes

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • Antibiotics Targeting Tuberculosis: Biosynthesis of A-102395 and Discovery of Novel Actinomycins

    Antibiotics Targeting Tuberculosis: Biosynthesis of A-102395 and Discovery of Novel Actinomycins

  • Supplementary Tables

    Supplementary Tables

  • Development of a Novel Anti-Infectivity Platform for the Treatment of Neglected Tropical and Infectious Diseases Andrea Marie Binnebose Iowa State University

    Development of a Novel Anti-Infectivity Platform for the Treatment of Neglected Tropical and Infectious Diseases Andrea Marie Binnebose Iowa State University

  • Drug-Resistant Tuberculosis 2020: Where We Stand

    Drug-Resistant Tuberculosis 2020: Where We Stand

  • Shortened Tuberculosis Treatment Regimens: What Is New? Denise Rossato Silva1 , Fernanda Carvalho De Queiroz Mello2 , Giovanni Battista Migliori3,4

    Shortened Tuberculosis Treatment Regimens: What Is New? Denise Rossato Silva1 , Fernanda Carvalho De Queiroz Mello2 , Giovanni Battista Migliori3,4

Top View
  • Final1-Aritmo-Final-Report-V2-0Final.Pdf
  • Common Study Protocol for Observational Database Studies WP5 – Analytic Database Studies
  • Bedaquiline: 10 Years Later, the Drug Susceptibility Testing Protocol Is Still Pending
  • Mechanisms of Drug Resistance in Mycobacterium Tuberculosis: Update 2015
  • Host-Directed Therapeutics As a Novel Approach for Tuberculosis Treatment Ye-Ram Kim1,2 and Chul-Su Yang1,2*
  • Regimen for Multidrug-Resistant Tuberculosis in Brazil, 2000–2015
  • Critically Important Antimicrobials for Human Medicine – 5Th Revision. Geneva
  • Tuberculosis Epidemiology, Pathogenesis, Drugs and Drug Resistance Development: a Review Bedaso Kebede1,2*
  • Guidelines for Drug Susceptibility Testing for Second-Line Anti-Tuberculosis Drugs for Dots-Plus
  • Public Assessment Report
  • Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
  • SIRTURO Safely and Effectively
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • Pharmacokinetic Study of Anti-Tb Drug Para-Aminosalicylic Acid and Its Metabolites: a Possible Relationship with the Development of Toxicity
  • Pharmacokinetics and Dosing Rationale of Para
  • Effectiveness and Safety of Clofazimine In€Multidrug-Resistant Tuberculosis
  • Deciphering Antimycobacterial Activity of Cyclophostin/Cyclipostins
  • Australian Statistics on Medicines 2009


© 2024 Docslib.org    Feedback